These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11162326)

  • 41. Women's trust in and use of information sources in the treatment of menopausal symptoms.
    Huston SA; Jackowski RM; Kirking DM
    Womens Health Issues; 2009; 19(2):144-53. PubMed ID: 19272565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hormone replacement therapy: attitude and acceptance of Bangkokian women.
    Taechakraichana N; Wilawan K; Wipatavit V; Maitrisathit S; Thamanavat N; Jaisamrarn U; Panyakhamlerd K; Havanond P; Limpaphayom KK
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S385-98. PubMed ID: 12930015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postmenopausal hormone therapy and migraine headache.
    Misakian AL; Langer RD; Bensenor IM; Cook NR; Manson JE; Buring JE; Rexrode KM
    J Womens Health (Larchmt); 2003 Dec; 12(10):1027-36. PubMed ID: 14709191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between premenopausal progestogen use and postmenopausal hormonal therapy in the GAZEL cohort.
    Ringa V; Fritel X; Varnoux N; Zins M; Piault S; Quelen C
    Maturitas; 2007 Nov; 58(3):216-25. PubMed ID: 17919857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy.
    Genazzani AR; Schneider HP; Panay N; Nijland EA
    Gynecol Endocrinol; 2006 Jul; 22(7):369-75. PubMed ID: 16864146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
    Lucas R; Barros H
    Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany.
    Heitmann C; Greiser E; Dören M
    Menopause; 2005; 12(4):405-11. PubMed ID: 16037755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reported satisfaction among women receiving hormone replacement therapy in a dedicated general practice clinic and in a normal consultation.
    Roberts PJ
    Br J Gen Pract; 1995 Feb; 45(391):79-81. PubMed ID: 7702887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knowledge of vitamin D and perceptions and attitudes toward sunlight among Chinese middle-aged and elderly women: a population survey in Hong Kong.
    Kung AW; Lee KK
    BMC Public Health; 2006 Sep; 6():226. PubMed ID: 16956420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Background factors influencing somatic and psychological symptoms in middle-age women with different hormonal status. A population-based study of Swedish women.
    Li C; Borgfeldt C; Samsioe G; Lidfeldt J; Nerbrand C
    Maturitas; 2005; 52(3-4):306-18. PubMed ID: 15967603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study.
    Rea TD; Psaty BM; Heckbert SR; Cushman M; Meilahn E; Olson JL; Lemaitre RN; Smith NL; Sotoodehnia N; Chaves PH
    J Womens Health (Larchmt); 2003 May; 12(4):341-50. PubMed ID: 12804341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trends in middle-aged women's reports of symptoms, use of hormone therapy and attitudes towards it.
    Ekström H
    Maturitas; 2005 Oct; 52(2):154-64. PubMed ID: 16186078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Provider management of menopause after the findings of the Women's Health Initiative.
    Rolnick SJ; Jackson J; Kopher R; Defor TA
    Menopause; 2007; 14(3 Pt 1):441-9. PubMed ID: 17318028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attitudes toward postmenopausal long-term hormone therapy.
    Kolip P; Hoefling-Engels N; Schmacke N
    Qual Health Res; 2009 Feb; 19(2):207-15. PubMed ID: 19050178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Attitude to and practice of Norwegian gynecologists concerning hormone replacement therapy in climacteric].
    Nilsen ST; Fredriksen T; Iversen OE; Moen MH
    Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2940-3. PubMed ID: 9748831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of media attention, family history, politics and maturation on women's decisions regarding hormone replacement therapy.
    Andrist LC
    Health Care Women Int; 1998; 19(3):243-60. PubMed ID: 9601305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors associated with use of hormone therapy among women with mobility impairments.
    Yang K; Becker H; Dormire S
    Women Health; 2006; 43(1):19-36. PubMed ID: 17050483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decision-making about the use of hormone therapy among perimenopausal women.
    Huston SA; Bagozzi RP; Kirking DM
    Br J Health Psychol; 2010 May; 15(Pt 2):231-51. PubMed ID: 19594986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deciding about hormone therapy: validation of a model.
    Woods NF; Falk S; Saver B; Taylor TR; Stevens N; MacLaren A
    Menopause; 1998; 5(1):52-9. PubMed ID: 9689195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.